Home  |  Contact Us  |  Investor Relations  |  Search:

>> About LeMaitre >> Investor Relations >> Investor Overview Investor Overview LeMaitre Vascular is a global provider of medical devices for the treatment of peripheral vascular disease. We develop, manufacture and market disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. Our devices are used to treat peripheral vascular disease, a condition that we estimate affects more than 20 million people worldwide. Our diversified portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart and are well known to vascular ... More >> LMAT (Common Stock) Exchange NASDAQ (US Dollar) Price $3.51 Change (%) 0.00 (0.00%) Volume 4,494 Data as of 08/19/08 4:00 p.m. ET Minimum 20 minute delay Refresh quote LeMaitre Vascular, Inc. Fact Sheet Recent News  RSS Feeds | More >> Date Title   08/11/08 LeMaitre Vascular to Present At Canaccord Adams 28th Annual Global Growth Conference 08/08/08 LeMaitre Vascular Receives Notice of Noncompliance With Nasdaq Marketplace Rule 07/29/08 LeMaitre Vascular Reports Q2 2008 Revenue of $12.7 Million, a 23% Increase 07/17/08 LeMaitre Vascular, Inc. Schedules Second Quarter Results and Conference Call Analyst Coverage Firm Analyst Goldman Sachs & Co. Lawrence Keusch Cowen & Co. Sarah Michelmore Thomas Weisel Partners LLC Philip Legendy Oppenheimer & Co. Amit  Hazan Jesup & Lamont Securities Corp. Kenneth Siri Receive E-mail Alerts Sign up to receive e-mail alerts whenever LeMaitre Vascular, Inc. posts new information to the site. Just enter your e-mail address and click Submit. Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.